The complexity of treatment after solid organ transplantation has been related to non-adherence to therapy prescriptions and to reduced graft survival. The aim of this study was to evaluate the middle-term effects of the conversion from Prograf (TAC), to extended-release tacrolimus (Advagraf) (ADV) in stable kidney transplant recipients.
Spagnoletti, G., Gargiulo, A., Salerno, M. P., Favi, E., Pedroso, J. A. R., Calia, R., Romagnoli, J., Citterio, F., Conversion from Prograf to Advagraf in stable kidney transplant recipients: better renal function after 3-year follow-up, <<TRANSPLANTATION PROCEEDINGS>>, 2014; 46 (7): 2224-2227. [doi:10.1016/j.transproceed.2014.08.003] [http://hdl.handle.net/10807/71576]
Conversion from Prograf to Advagraf in stable kidney transplant recipients: better renal function after 3-year follow-up
Spagnoletti, Gionata;Gargiulo, Antonio;Salerno, Maria Paola;Favi, Evaldo;Pedroso, José Alberto Rodrigues;Calia, Rosaria;Romagnoli, Jacopo;Citterio, Franco
2014
Abstract
The complexity of treatment after solid organ transplantation has been related to non-adherence to therapy prescriptions and to reduced graft survival. The aim of this study was to evaluate the middle-term effects of the conversion from Prograf (TAC), to extended-release tacrolimus (Advagraf) (ADV) in stable kidney transplant recipients.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
